November 29, 2022
Ever wondered where money raised at events such as South Burnett Relay For Life end up?
Cancer Council Queensland recently announced a $2 million boost to cancer research at their annual Accelerating Collaborative Cancer Research (ACCR) presentation.
In partnership with the University of Queensland, Cancer Council Queensland will invest $2 million over four years in a project targeting oesophageal cancer.
Lead Researcher Professor Andrew Barbour will be funded for his project, “Assessment of tumour phenotype for precision medicine in oesophageal cancer via deep learning analysis of medical images”.
A Cancer Council Queensland spokesperson said the ACCR grants were highly competitive.
They aim to:
- Stimulate innovative, collaborative cancer research to make major advances in areas of need,
- Accelerate the translation of research findings into improved prevention, clinical practice or health policy to improve the survival and well-being of cancer patients, and
- Develop the capacity of high-quality cancer research groups in Queensland by encouraging effective research collaboration between universities, health services and medical and scientific research institutes.
Cancer Council Queensland CEO Andrew Donne congratulated the successful research team.
“Thanks to our generous supporters, Cancer Council Queensland is proud to accelerate Prof Andrew Barbour’s project and provide hope for the 31,000 Queenslanders diagnosed with cancer each year,” he said.
Prof Barbour expressed heartfelt thanks to Cancer Council Queensland and its supporters.
“Oesophageal cancer has a poor prognosis and there are few treatment options,” he said.
“We aim to extract information from medical imaging to support better treatment decisions and outcomes for patients through a precision medicine approach.”
